| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.22B | 44.80B | 42.90B | 40.02B | 32.27B | 21.13B |
| Gross Profit | 5.36B | 5.12B | 4.33B | 3.03B | 979.00M | -4.27B |
| EBITDA | 2.78B | 2.60B | 1.80B | 701.00M | -672.00M | -5.50B |
| Net Income | 2.62B | 434.00M | 1.92B | 912.00M | 73.00M | -4.99B |
Balance Sheet | ||||||
| Total Assets | 24.82B | 36.90B | 24.56B | 23.82B | 21.57B | 20.09B |
| Cash, Cash Equivalents and Short-Term Investments | 11.63B | 10.05B | 10.81B | 8.65B | 6.14B | 6.44B |
| Total Debt | 2.90B | 10.82B | 3.13B | 5.78B | 3.58B | 4.93B |
| Total Liabilities | 20.53B | 29.67B | 20.27B | 20.60B | 19.80B | 18.73B |
| Stockholders Equity | 4.29B | 7.22B | 4.29B | 3.22B | 1.76B | 1.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.47B | 5.16B | 409.00M | 64.00M | -5.25B |
| Operating Cash Flow | 0.00 | 1.56B | 5.27B | 529.00M | 122.00M | -5.23B |
| Investing Cash Flow | 0.00 | -1.51B | -427.00M | -267.00M | -159.00M | 1.07B |
| Financing Cash Flow | 0.00 | -998.00M | -2.65B | 2.17B | -356.00M | -5.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥7.63B | 7.03 | ― | 0.47% | 1.93% | 1.91% | |
68 Neutral | ¥1.15T | 11.48 | 11.50% | 3.11% | 9.13% | 29.20% | |
68 Neutral | ¥1.33T | 9.92 | ― | 1.97% | 12.26% | 11.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | ¥7.23B | 3.59 | ― | ― | 4.42% | -93.47% | |
50 Neutral | ¥6.58B | 13.74 | ― | 0.30% | -2.16% | 25.35% |